Vasopressin and prevention of hypotension during hemodialysis

Iranian Red Crescent Medical Journal
Seyed Seifollah Beladi Mousavi, Mohamad Reza Tamadon

Abstract

The occurrence of intradialytic hypotension (IDH) during hemodialysis (HD) continues to be a main problem in patients with ESRD (end-stage kidney disease). It also negatively affects health-related quality of life. We aimed to determine vasopressin effect in decreasing IDH. We reviewed clinical and experimental literature in a variety of sources, including PubMed, Current Content, Scopus, Embase, and Iranmedex regarding the possible effect of vasopressin administration in prevention of hypotension during HD to clarify its mechanism, efficacy, and safety. Although arginine vasopressin is widely recognized for its anti-diuretic properties, it is also a well-recognized vasoconstrictor. It has been shown that the vasopressin release (as it would normally be expected) does not increase in the majority of HD patients with recurrent dialysis hypotension. In addition, it has also been reported that vasopressin secretion (due to the osmotic stimulation) is the most important mechanism in blood pressure control in ESRD patients receiving hypertonic solution for IDH. Therefore, it is suggested that vasopressin administration may improve hemodynamic stability among ESRD patients during HD. There are few clinical trials about this issue, su...Continue Reading

References

Jan 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F DumlerN W Levin
Jan 1, 1990·American Journal of Nephrology·J S LindbergD Goode
Oct 1, 1986·Kidney International·W L Henrich
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·S NielsenM A Knepper
Jul 1, 1995·Annals of Internal Medicine·K YokokawaA K Mandel
May 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G L SangC M Kjellstrand
Apr 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D N CruzM A Perazella
Jun 30, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J DonauerJ Böhler
Nov 10, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F M van der SandeK M Leunissen
Oct 17, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M A Perazella
Oct 27, 2001·Seminars in Dialysis·S StillerH Mann
Jun 13, 2002·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Violaine BéginFrançois Madore
Mar 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliMohammed Yaqoob
Jul 29, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Suma PrakashAndrew A House
Aug 4, 2005·Seminars in Dialysis·Gary G Schwartz
Aug 18, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Judith J DasselaarCasper F M Franssen
Sep 30, 2005·Seminars in Dialysis·Naveed N MasaniJohn K Maesaka
Oct 6, 2005·Current Opinion in Nephrology and Hypertension·Martin K KuhlmannNathan W Levin
Feb 25, 2006·Journal of the American Society of Nephrology : JASN·Kailash JindalUNKNOWN Canadian Society of Nephrology Committee for Clinical Practice Guidelines
Feb 28, 2006·Kidney International·M KraemerV Wizemann
Sep 28, 2006·Kidney International·S van der ZeeJ A Oliver
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·J Matthew BrennanKirk T Spencer
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Clément DézielFrançois Madore
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Carlo BasileNicola D'Ambrosio
Jan 8, 2008·Journal of the American Society of Nephrology : JASN·Biff F Palmer, William L Henrich
Feb 8, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Mira RhoUrsula C Brewster
Jun 20, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kurakazu ShimizuTeizo Sanjo
Feb 11, 2009·Clinical Nephrology·M MilinkovicB Stojimirovic
Jun 3, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kurakazu ShimizuTeizo Sanjo
Feb 2, 2012·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Seyed S Beladi-MousaviMehdi Talebzadeh

❮ Previous
Next ❯

Citations

Apr 24, 2018·BioMed Research International·Scott McGuireGordon McGregor

❮ Previous
Next ❯

Software Mentioned

Iranmedex

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.